<?xml version="1.0" encoding="UTF-8"?>
<table id="PMC6509602/table_3" xmlns="http://www.w3.org/1999/xhtml">
 <caption>
  <label>Table 3</label>
  <p>Responses to open-ended questions on antimicrobial resistance (AMR)</p>
 </caption>
 <thead>
  <tr>
   <td align="left" valign="bottom" style="background-color:#D9D9D9;" rowspan="1" colspan="1" id="0-0-.">Question</td>
   <td align="left" valign="bottom" style="background-color:#D9D9D9;" rowspan="1" colspan="1" id="0-1-.">Responses</td>
  </tr>
 </thead>
 <tbody>
  <tr>
   <td align="left" valign="top" rowspan="1" colspan="1">
    <b>Nightmare scenario</b>
   </td>
   <td align="left" valign="top" rowspan="1" colspan="1">
    <ul list-type="bullet">
     <li class="list-item">
      <p>Global spread and dominance of totally antimicrobial resistant pathogens—returning to the preantibiotic era</p>
     </li>
    </ul>
   </td>
  </tr>
  <tr>
   <td align="left" valign="top" rowspan="1" colspan="1">
    <b>Priorities for future research/policy</b>
   </td>
   <td align="left" valign="top" rowspan="1" colspan="1">
    <ul list-type="bullet">
     <li class="list-item">
      <p>Environmental impact of antimicrobial use in humans, animals and crops</p>
     </li>
     <li class="list-item">
      <p>Emerging bacterial resistance to biocides and disinfectants.</p>
     </li>
     <li class="list-item">
      <p>AMR transmission from and to companion animals.</p>
     </li>
     <li class="list-item">
      <p>Balancing food production capacity with AMR concerns.</p>
     </li>
     <li class="list-item">
      <p>Need for comprehensive AMR surveillance; understanding the selection, expansion and spread of multidrug-resistant mobile genetic elements (mapping the mobile gene pool).</p>
     </li>
     <li class="list-item">
      <p>Antibiotic stewardship—understanding why doctors prescribe and patients demand, antimicrobials inappropriately.</p>
     </li>
     <li class="list-item">
      <p>Better infection control within health and aged care facilities.</p>
     </li>
     <li class="list-item">
      <p>Point-of-care diagnostics (including rapid species identification and drug susceptibility testing).</p>
     </li>
     <li class="list-item">
      <p>Use of highly selective bacteriophage therapy.</p>
     </li>
     <li class="list-item">
      <p>Adaptive clinical trial designs for rapid assessment of multidrug regimens</p>
     </li>
     <li class="list-item">
      <p>Alternative drug development funding models that considers the public good.</p>
     </li>
     <li class="list-item">
      <p>Non-antimicrobial approaches to controlling infections.</p>
     </li>
    </ul>
   </td>
  </tr>
  <tr>
   <td align="left" valign="top" rowspan="1" colspan="1">
    <b>Most important research question</b>
   </td>
   <td align="left" valign="top" rowspan="1" colspan="1">
    <ul list-type="bullet">
     <li class="list-item">
      <p>Are there effective treatment strategies that will reduce selective pressure and on-going evolutionary ‘escape’, such as increasing bacterial susceptibility to immune attack or reducing the risk/impact of invasive bacterial infection only?</p>
     </li>
     <li class="list-item">
      <p>What are the key characteristics of a healthy microbiome and the short and long term impacts of antimicrobial induced changes?</p>
     </li>
    </ul>
   </td>
  </tr>
  <tr>
   <td align="left" valign="top" rowspan="1" colspan="1">
    <b>Issues that require public consultation</b>
   </td>
   <td align="left" valign="top" rowspan="1" colspan="1">
    <ul list-type="bullet">
     <li class="list-item">
      <p>Restricting antimicrobial access to reduce inappropriate use, for example stronger regulation or increases in price</p>
     </li>
     <li class="list-item">
      <p>How best to educate the general public and prescribers about the dangers (personal and environmental) of inappropriate antimicrobial use.</p>
     </li>
     <li class="list-item">
      <p>Balancing animal and human welfare considerations.</p>
     </li>
     <li class="list-item">
      <p>Balancing distributive justice and community versus individual cost–benefit.</p>
     </li>
    </ul>
   </td>
  </tr>
 </tbody>
 <tfoot>
  <p class="fn" charset="fn" id="T3_FN1">
   <p>AMR, antimicrobial resistance.</p>
  </p>
 </tfoot>
</table>
